U.S. Markets closed

Zacks.com featured highlights: AngioDynamics, Luxoft Holding, Boston Scientific, Popeyes Louisiana Kitchen and Thermo Fisher Scientific

Zacks Equity Research

For Immediate Release

Chicago, IL – October 26, 2016 - Stocks in this week’s article include AngioDynamics Inc. (NASDAQ:ANGO –Free Report),Luxoft Holding, Inc. (NYSE:LXFT –Free Report),Boston Scientific Corporation (NYSE:BSX –Free Report),Popeyes Louisiana Kitchen, Inc. (NASDAQ:PLKI –Free Report) and Thermo Fisher Scientific, Inc. (NYSE:TMO – Free Report).

Screen of the Week of Zacks Investment Research:

5 GARP Stocks Well-Positioned to Provide Impressive Yields

Stocks that have impressive growth prospects but are undervalued may prove to be one of the best investment options in the equity market. The strategy of finding stocks on the basis of the above criteria is widely known as growth at a reasonable price or GARP. This strategy is particularly profitable in markets that are witnessing a strong rebound after a massive slump.

However, one should not confuse GARP investing with the blend strategy. While the blend strategy seeks to invest in both value and growth stocks, GARP investing requires both value and growth features in a single stock.

Key Features of GARP

The GARP strategy seeks to offer an ideal investment by borrowing the best features of both value and growth investing. While investors following the GARP strategy give precedence to value ratios such as price-to-earnings (P/E) and price-to-book value (P/B) ratio, they also use earnings per share (EPS) growth rates and return on equity (ROE) like growth investors to identify potential stocks. However, the range of the values of metrics that are considered by GARP investing may differ from those that are considered by value or growth investors.

While value investors look for an extremely low P/E ratio to choose a company, the GARP strategy focuses on acquiring stocks that have relatively higher ratios but less than their respective industry average. Meanwhile, GARP investing chooses stocks with P/B ratios lower than their industries similar to value investors.

Separately, investors following the GARP strategy give priority to stocks with an impressive EPS growth track record over those with extremely high growth rates. Companies that qualify GARP investing are believed to have past as well as expected growth rates over the next few years between 10% and 20%.

Another metric, which is borrowed by GARP investors from growth investing, is return on equity (ROE). Like growth investors, the GARP strategy looks for stocks with higher ROE than their industry average.

Screening Parameters

Along with the criteria we discussed in the above section, we have also considered favorable Zacks Rank – Zacks Rank #1 (Strong Buy) or #2 (Buy) – to make the strategy more profitable.

• Zacks Rank less than or equal to #2
(Only Strong Buy and Buy rated stocks can get through.)

Last 5-year EPS & projected 3–5 year EPS growth rates between 10% and 20%
(Strong EPS growth history and prospects ensure improving business.)

ROE (over the past 12 months) greater than the industry average
(Higher ROE compared to the industry average indicates superior stocks.)

P/E and P/B ratios less than X-industry average
(P/E and P/B ratios less than that of the industry indicate that the stocks are undervalued.)

Just these few criteria have narrowed down the universe of over 7,700 stocks to only five.

Here are the five stocks that made it through the screen:

AngioDynamics Inc. (NASDAQ:ANGO – Free Report) is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians. It has an average four-quarter positive earnings surprise of 16.2% and sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here .

Luxoft Holding, Inc. (NYSE:LXFT – Free Report) offers software development services and information technology solutions. This Zacks Rank #2 stock has an average four-quarter positive earnings surprise of 19.3%.

Boston Scientific Corporation (NYSE:BSX – Free Report) is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. This Zacks Rank #2 stock has an average four-quarter positive earnings surprise of 6.3%.

Popeyes Louisiana Kitchen, Inc. (NASDAQ:PLKI – Free Report) owns, operates and franchises a chain of quick-service restaurants. This Zacks Rank #2 stock has an expected earnings growth rate of 10.4% for the current year compared with the industry average of 8.6%.

Thermo Fisher Scientific, Inc. (NYSE:TMO – Free Report) provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. This Zacks Rank #2 stock has an average four-quarter positive earnings surprise of 1.5%.

Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and back-testing software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today .

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance .

Zacks Restaurant Recommendations: In addition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »

Sign up now for your free trial today and start picking better stocks immediately. And with the backtesting feature, you can test your ideas to see how you can improve your trading in both up markets and down markets. Don’t wait for the market to get better before you decide to do better. Start learning how to be a better trader today: https://at.zacks.com/?id=111

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here https://at.zacks.com/?id=112

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.

Get the full Report on ANGO - FREE

Get the full Report on LXFT - FREE

Get the full Report on BSX - FREE

Get the full Report on PLKI - FREE

Get the full Report on TMO - FREE

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com

Visit: https://www.zacks.com/performance

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer .

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ANGIODYNAMICS (ANGO): Free Stock Analysis Report
LUXOFT HOLDING (LXFT): Free Stock Analysis Report
BOSTON SCIENTIF (BSX): Free Stock Analysis Report
THERMO FISHER (TMO): Free Stock Analysis Report
POPEYES LA KTCH (PLKI): Free Stock Analysis Report
To read this article on Zacks.com click here.